机译:新型顺磁性AT1受体拮抗剂
ARC Centre of Excellence for Free Radical Chemistry and Biotechnology, Victoria, Australia,School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Victoria, 3010, Australia;
ARC Centre of Excellence for Free Radical Chemistry and Biotechnology, Victoria, Australia,School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Victoria, 3010, Australia;
ARC Centre of Excellence for Free Radical Chemistry and Biotechnology, Victoria, Australia,School of Physical and Chemical Sciences, Queensland University of Technology, GPO Box 2432, Brisbane, QLD 4001, Australia;
ARC Centre of Excellence for Free Radical Chemistry and Biotechnology, Victoria, Australia,Department of Pharmacology, The University of Melbourne,Victoria, 3010, Australia;
ARC Centre of Excellence for Free Radical Chemistry and Biotechnology, Victoria, Australia,Department of Pharmacology, The University of Melbourne,Victoria, 3010, Australia;
School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Victoria, 3010, Australia;
ARC Centre of Excellence for Free Radical Chemistry and Biotechnology, Victoria, Australia,School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Victoria, 3010, Australia;
ARC Centre of Excellence for Free Radical Chemistry and Biotechnology, Victoria, Australia,Department of Pharmacology, The University of Melbourne,Victoria, 3010, Australia;
机译:血管紧张素转换酶抑制剂与AT1受体拮抗剂在心血管和肾脏保护中的关系:AT1受体拮抗剂的情况。
机译:用碳-11-L-159,884研究血管紧张素II / AT1受体:一种选择性的AT1拮抗剂。
机译:AT1受体拮抗剂ZD 7155和AT2受体拮抗剂PD 123319在有意识的羔羊中的全身和肾脏血液动力学作用。
机译:血管紧张素II通过L-Name诱导的高血压大鼠AT1受体增强肾血管收缩
机译:F-18标记的氟吡啶氯沙坦类似物作为新型PET示踪剂,用于AT1受体成像的合成和初步评估。
机译:通过使用表达人血管紧张素II AT1受体的CHO-K1细胞来区分可克服和不可克服的选择性AT1受体拮抗剂
机译:通过使用表达人血管紧张素II AT1受体的CHO-K1细胞来区分可克服和不可克服的选择性AT1受体拮抗剂